|Parkinsonís Institute and Berg Biomarker Collaboration Featured in this Monthís Drug Discovery News|
|Published Thursday, April 17, 2014 8:00 am|
Birgitt Schuele, MD, Director of Gene Discovery and Stem Cell Modeling at the Parkinson’s Institute and Clinical Center and Niven R. Narian, Co-Founder, President, and Chief Technology Officer at Berg were recently interviewed by Drug Discovery News about our ongoing collaboration and first-of-its-kind approach to Parkinson’s disease biomarker discovery.
Please Note: News Article is for educational and informational purposes only. Learn more about Clinical Trials and Clinical Studies at the Parkinson’s Institute here.